Gastric Acid–Inhibiting Medications and Vitamin B12 Deficiency

• Autores: T.S. Dharmarajan, Edward P. Norkus
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 311, Nº. 14, 2014, págs. 1445-1445
• Idioma: inglés
• Enlaces
  • Texto Completo Ejemplar
• Resumen

  • Mr Lam and colleagues1 reported that previous and current gastric acid–inhibiting medication use for 2 or more years (proton pump inhibitors [PPIs] and histamine 2 receptor antagonists [H2RAs]) was associated with a greater risk of vitamin B12 deficiency; this association became stronger with increasing daily consumption of PPIs or H2RAs. The study is, to date, the largest study suggesting a relationship between PPIs or H2RAs and vitamin B12 deficiency. Lam et al1 confirmed and extended the results from 2 earlier, small studies2,3 that also suggested PPI use was associated with diminished vitamin B12 status.